Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 24;531(7595):518-22.
doi: 10.1038/nature17161.

Melanoma addiction to the long non-coding RNA SAMMSON

Affiliations

Melanoma addiction to the long non-coding RNA SAMMSON

Eleonora Leucci et al. Nature. .

Abstract

Focal amplifications of chromosome 3p13-3p14 occur in about 10% of melanomas and are associated with a poor prognosis. The melanoma-specific oncogene MITF resides at the epicentre of this amplicon. However, whether other loci present in this amplicon also contribute to melanomagenesis is unknown. Here we show that the recently annotated long non-coding RNA (lncRNA) gene SAMMSON is consistently co-gained with MITF. In addition, SAMMSON is a target of the lineage-specific transcription factor SOX10 and its expression is detectable in more than 90% of human melanomas. Whereas exogenous SAMMSON increases the clonogenic potential in trans, SAMMSON knockdown drastically decreases the viability of melanoma cells irrespective of their transcriptional cell state and BRAF, NRAS or TP53 mutational status. Moreover, SAMMSON targeting sensitizes melanoma to MAPK-targeting therapeutics both in vitro and in patient-derived xenograft models. Mechanistically, SAMMSON interacts with p32, a master regulator of mitochondrial homeostasis and metabolism, to increase its mitochondrial targeting and pro-oncogenic function. Our results indicate that silencing of the lineage addiction oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific manner; this silencing is therefore expected to deliver highly effective and tissue-restricted anti-melanoma therapeutic responses.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Cell Death Differ. 2015 Nov;22(11):1812-23 - PubMed
    1. Neuroscience. 2011 Dec 29;199:346-58 - PubMed
    1. Pigment Cell Melanoma Res. 2010 Aug;23(4):496-513 - PubMed
    1. Oncotarget. 2015 Jan 20;6(2):1157-70 - PubMed
    1. Mol Cell Biol. 2010 Mar;30(6):1303-18 - PubMed

Publication types

MeSH terms

Associated data